Burning Rock Biotech (Burning Rock Biotech) Other Current Receivables : $7.99 Mil (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Burning Rock Biotech Other Current Receivables?

Burning Rock Biotech's Other Current Receivables for the quarter that ended in Sep. 2023 was $7.99 Mil.

Burning Rock Biotech's quarterly Other Current Receivables increased from Mar. 2023 ($7.10 Mil) to Jun. 2023 ($8.21 Mil) but then stayed the same from Jun. 2023 ($8.21 Mil) to Sep. 2023 ($7.99 Mil).

Burning Rock Biotech's annual Other Current Receivables increased from Dec. 2020 ($9.01 Mil) to Dec. 2021 ($10.32 Mil) but then declined from Dec. 2021 ($10.32 Mil) to Dec. 2022 ($8.65 Mil).

Burning Rock Biotech Other Current Receivables Historical Data

The historical data trend for Burning Rock Biotech's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burning Rock Biotech Other Current Receivables Chart

Burning Rock Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Current Receivables

Get a 7-Day Free Trial

6.92

17.07

9.01

10.32

8.65

Burning Rock Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Current Receivables	Get a 7-Day Free Trial															6.64	8.65	7.10	8.21	7.99

Burning Rock Biotech Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Burning Rock Biotech Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Burning Rock Biotech's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Burning Rock Biotech (Burning Rock Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Burning Rock Biotech Ltd (NAS:BNR) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

BNR:UK 6BUA:Germany

Address

No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005

Website

https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.